Abstract:Objective: To investigate the effect of interleukin-25 (IL-25) on ovalbumin (OVA) induced atopic dermatitis of mice, and the significance of regulating IL-25. Methods: In this study, 90 healthy male 6-week-old specific pathogen free (SPF) BALB/c mice were divided into 6 groups (15 in each group): ① subcutaneous injection of phosphate buffered saline (PBS) group (normal control group); ② subcutaneous injection of mouse IL-25 group (IL-25 group); ③ subcutaneous injection of anti-mouse IL-25 monoclonal antibody (anti-IL-25 group), each group received subcutaneous injection once a day for 1 week, 2 weeks apart, repeated daily subcutaneous injections for 1 week, 2 weeks apart, and repeated daily subcutaneous injections for 1 week, for a total of 7 weeks; ④ OVA treated group (model group); ⑤ OVA treated and IL-25 subcutaneous injection group (IL-25 treated dermatitis group); ⑥ OVA treated and anti-mouse IL-25 monoclonal antibody injection group (anti-IL-25 treated dermatitis group). The ⑤ and ⑥ groups in the process of treatment with OVA, IL-25 or anti-IL-25 antibody were given in the same way as the ② and ③ groups. Scratching behavior and skin performance of the mice were recorded during the seven-week-treatment. Twenty four hours after the final treatment, blood was taken from the mouse heart, and the serum was separated to detect the total IgE, IL-4, IL-5, IL-13, etc. The skin samples of the treatment sites were used for hematoxylin-eosin (HE) staining, immunohistochemistry, real-time PCR and Western blot detections. A single factor (ANOVA) analysis of variance was used to compare the differences in various indicators between the groups. Results: The frequency of scratches in the IL-25 treated dermatitis group was higher than that in the model group, and the scratching behavior of the anti-IL-25 treated dermatitis group was significantly lower than that in the model group. The appearance of atopic dermatitis, thickening of the epidermis and the degree of dermal inflammation in the IL-25 treated dermatitis group were more serious than those in the model group and the anti-IL-25 treated dermatitis group. The levels of serum IgE, IL-4, IL-5, and IL-13 in the IL-25 treated dermatitis group were significantly higher than that in the model group and the anti-IL-25 treated dermatitis group. There were significantly more CD4+ T cells in the dermis of IL-25 treated dermatitis group than that in the anti-IL-25 treated dermatitis group. The expression levels of filaggrin and defensin β2 proteins in the IL-25 treated dermatitis group were significantly lower than those in the model group and the anti-IL-25 treated dermatitis group. Conclusion: In the OVA induced atopic dermatitis mice model, IL-25 can significantly promote the damage of the epidermal barrier function and aggravate the OVA-induced dermatitis. Antagonizing IL-25 can alleviate OVA induced dermatitis to a certain extent.

IL-4 receptor alpha blockade in mice reduces skin inflammation, systemic response and the atopic march

S100A4 is Critical for a Mouse Model of Allergic Asthma by Impacting Mast Cell Activation.

Exaggerated IL-17 Response to Epicutaneous Sensitization Mediates Airway Inflammation in the Absence of IL-4 and IL-13.

Soluble IL-4 Receptor Inhibits Airway Inflammation Following Allergen Challenge in a Mouse Model of Asthma1

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

Reduced Serum Antibody Production and Acute Airway Inflammation in Interleukin 6-deficient Mice Challenged with Ovalbumin

Interleukin-17 Orchestrates the Granulocyte Influx into Airways after Allergen Inhalation in A Mouse Model of Allergic Asthma

Epicutaneous Antigen Challenge of Orally Sensitized Mice Elicits Allergic Dermatitis by Redirecting Α4β7 Gut Homing T Cells to the Skin (79.7)

Enhanced Airway Inflammation and Decreased Subepithelial Fibrosis in Interleukin 6‐deficient Mice Following Chronic Exposure to Aerosolized Antigen

Effects of anti-IgE antibody on airway resistance and levels of Th2 cytokines in asthmatic mouse and its mechanisms

Cd4(+)Cd25(+) Regulatory T Cells Decreased Cd8(+)Il-4(+) Cells In A Mouse Model Of Allergic Asthma

Atopic Dermatitis Enhanced Ovalbumin-Induced Airway Inflammation in Mice

Topical Emollient Prevents the Development of Atopic Dermatitis and Atopic March in Mice.

Epicutaneous Sensitization with Ovalbumin, Staphylococcal Enterotoxin B and Vitamin D Analogue Induces Atopic Dermatitis in Mice.

Epicutaneous Antigen Exposure Induces A Th17 Response That Drives Airway Inflammation After Inhalation Challenge

4-1Bbl/4-1bb Costimulation Alleviates Airway Inflammation by Restoring Treg/Th17 Balance in Allergic Asthma

Exclusion of Il-21 in the Pathogenesis of Ova-Induced Asthma in Mice

[The role and its regulatory significance of interleukin-25 in ovalbumin induced atopic dermatitis of mice]

Ablation of Eosinophils Leads to a Reduction of Allergen-Induced Pulmonary Pathology.

Il-12-Dependent Vascular Cell Adhesion Molecule-1 Expression Contributes to Airway Eosinophilic Inflammation in A Mouse Model of Asthma-Like Reaction

Induction of Immune Tolerance and Reduction of Aggravated Lung Eosinophilia by Co-Exposure to Asian Sand Dust and Ovalbumin for 14 Weeks in Mice